BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11517319)

  • 1. The coreceptor mutation CCR5Delta32 influences the dynamics of HIV epidemics and is selected for by HIV.
    Sullivan AD; Wigginton J; Kirschner D
    Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10214-9. PubMed ID: 11517319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and the role of CCR5Δ32 heterozygosity in disease progression in HIV positive patients in the Czech Republic.
    Sácká L; Hodek J; Machala L; Malý M; Weber J
    Epidemiol Mikrobiol Imunol; 2019; 68(3):138-143. PubMed ID: 31914779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased susceptibility of peripheral blood mononuclear cells from individuals heterozygous for a mutant CCR5 allele to HIV infection.
    Kim A; Pettoello-Mantovani M; Goldstein H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Oct; 19(2):145-9. PubMed ID: 9768623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR5Delta32 genotypes in a German HIV-1 seroconverter cohort and report of HIV-1 infection in a CCR5Delta32 homozygous individual.
    Oh DY; Jessen H; Kücherer C; Neumann K; Oh N; Poggensee G; Bartmeyer B; Jessen A; Pruss A; Schumann RR; Hamouda O
    PLoS One; 2008 Jul; 3(7):e2747. PubMed ID: 18648518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restriction of HIV type 1 infection in macrophages heterozygous for a deletion in the CC-chemokine receptor 5 gene.
    Ometto L; Zanchetta M; Cabrelle A; Esposito G; Mainardi M; Chieco-Bianchi L; De Rossi A
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1441-52. PubMed ID: 10555107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the genetic variant CCR5Δ32 in HBV infection and HBV/HIV co-infection.
    Ellwanger JH; Kulmann-Leal B; Wolf JM; Michita RT; Simon D; Lunge VR; Chies JAB
    Virus Res; 2020 Feb; 277():197838. PubMed ID: 31837381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low frequency of the ccr5delta32 HIV-resistance allele in mainland China: identification of the first case of ccr5delta32 mutation in the Chinese population.
    Jiang JD; Wang Y; Wang ZZ; Chen XH; Guo ZM; Pan HL; Bekesi GJ; Wang AX; Chen HS
    Scand J Infect Dis; 1999; 31(4):345-8. PubMed ID: 10528870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CCR5 receptor acts as an alloantigen in CCR5Delta32 homozygous individuals: identification of chemokineand HIV-1-blocking human antibodies.
    Ditzel HJ; Rosenkilde MM; Garred P; Wang M; Koefoed K; Pedersen C; Burton DR; Schwartz TW
    Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5241-5. PubMed ID: 9560260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of heterozygous CCR5Δ32 deletion with survival in HIV-infection: A cohort study.
    Ruiz-Mateos E; Tarancon-Diez L; Alvarez-Rios AI; Dominguez-Molina B; Genebat M; Pulido I; Abad MA; Muñoz-Fernandez MA; Leal M
    Antiviral Res; 2018 Feb; 150():15-19. PubMed ID: 29221798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to Human Immunodeficiency Virus 1 Infection Conferred by a Compound CCR5Δ32 and CCR5 C20S Heterozygote.
    Alkhatib B; Jabari M; Bilasy S; Abdul-Rahman H; Sandhu K; Lai S; Alkhatib G
    J Infect Dis; 2023 Jul; 228(2):116-121. PubMed ID: 36912158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. French Pediatric HIV Infection Study Group.
    Misrahi M; Teglas JP; N'Go N; Burgard M; Mayaux MJ; Rouzioux C; Delfraissy JF; Blanche S
    JAMA; 1998 Jan; 279(4):277-80. PubMed ID: 9450710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of CCR5Δ32 allele in healthy Bosniak population.
    Adler G; Valjevac A; Skonieczna-Żydecka K; Mackic-Djurovic M; Parczewski M; Urbańska A; Salkic NN
    Bosn J Basic Med Sci; 2014 Aug; 14(3):150-4. PubMed ID: 25172974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Frequency of CCR5del32 Mutation in Populations of Russians, Tatars and Bashkirs of Chelyabinsk Region, Russia.
    Govorovskaya I; Khromova E; Suslova T; Alexeev L; Kofiadi I
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):109-112. PubMed ID: 28083604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of CCR5-Δ32 mutation among individuals with high risk behaviors, neonates born to HIV-1 infected mothers, HIV-1 infected individuals, and healthy people in an Iranian population.
    Donyavi T; Bokharaei-Salim F; Nahand JS; Garshasbi S; Esghaei M; Sadeghi M; Jamshidi S; Khanaliha K
    J Med Virol; 2020 Aug; 92(8):1158-1164. PubMed ID: 31854469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of the CCR5Delta32 mutation in Brazilian populations and cell susceptibility to HIV-1 infection.
    Grimaldi R; Shindo N; Acosta AX; Dourado I; Brites C; de Melo Carvalho O; Brito I; Bou-Habib DC; Galvão-Castro B
    Hum Genet; 2002 Jul; 111(1):102-4. PubMed ID: 12136242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association analysis and allelic distribution of deletion in CC chemokine receptor 5 gene (CCR5Δ32) among breast cancer patients of Pakistan.
    Fatima F; Saleem S; Hameed A; Haider G; Ali Zaidi SA; Kanwal M; Zehra S; Azhar A
    Mol Biol Rep; 2019 Apr; 46(2):2387-2394. PubMed ID: 30848448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The frequency of CCR5Delta32 and CCR2-64I in southern Iranian normal population.
    Gharagozloo M; Doroudchi M; Farjadian S; Pezeshki AM; Ghaderi A
    Immunol Lett; 2005 Jan; 96(2):277-81. PubMed ID: 15585333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells.
    Agrawal L; Lu X; Qingwen J; VanHorn-Ali Z; Nicolescu IV; McDermott DH; Murphy PM; Alkhatib G
    J Virol; 2004 Mar; 78(5):2277-87. PubMed ID: 14963124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of the CCR5Delta32 HIV-resistance mutation among Estonian HIV type 1-infected individuals.
    Adojaan M; Mölder T; Männik A; Kivisild T; Villems R; Krispin T; Ustav M
    AIDS Res Hum Retroviruses; 2007 Feb; 23(2):193-7. PubMed ID: 17331026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of CCR5 gene 32-basepair deletion in Chilean HIV-1 infected and non-infected individuals.
    Desgranges C; Carvajal P; Afani A; Guzman MA; Sasco A; Sepulveda C
    Immunol Lett; 2001 Mar; 76(2):115-7. PubMed ID: 11274729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.